Reduced red cell transfusions and hospitalizations in sickle cell patients treated with voxelotor—Experience from a single center

Transfusion(2022)

引用 0|浏览2
暂无评分
摘要
TransfusionVolume 62, Issue 7 p. 1462-1464 LETTER Reduced red cell transfusions and hospitalizations in sickle cell patients treated with voxelotor—Experience from a single center Najeebah A. Bade, Najeebah A. Bade Adult Sickle Center, Inova Schar Cancer Institute, Fairfax, Virginia, USASearch for more papers by this authorUpama Giri, Upama Giri Adult Sickle Center, Inova Schar Cancer Institute, Fairfax, Virginia, USASearch for more papers by this authorHongkun Wang, Hongkun Wang Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown University Medical Center, Washington, District of Columbia, USASearch for more papers by this authorWilliam B. Ershler, Corresponding Author William B. Ershler william.ershler@inova.org orcid.org/0000-0001-8160-7661 Adult Sickle Center, Inova Schar Cancer Institute, Fairfax, Virginia, USA Correspondence William B. Ershler, Adult Sickle Center, Inova Schar Cancer Institute, Fairfax, VA 22031, USA. Email: william.ershler@inova.orgSearch for more papers by this author Najeebah A. Bade, Najeebah A. Bade Adult Sickle Center, Inova Schar Cancer Institute, Fairfax, Virginia, USASearch for more papers by this authorUpama Giri, Upama Giri Adult Sickle Center, Inova Schar Cancer Institute, Fairfax, Virginia, USASearch for more papers by this authorHongkun Wang, Hongkun Wang Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown University Medical Center, Washington, District of Columbia, USASearch for more papers by this authorWilliam B. Ershler, Corresponding Author William B. Ershler william.ershler@inova.org orcid.org/0000-0001-8160-7661 Adult Sickle Center, Inova Schar Cancer Institute, Fairfax, Virginia, USA Correspondence William B. Ershler, Adult Sickle Center, Inova Schar Cancer Institute, Fairfax, VA 22031, USA. Email: william.ershler@inova.orgSearch for more papers by this author First published: 11 July 2022 https://doi.org/10.1111/trf.16989Citations: 1Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article. Volume62, Issue7July 2022Pages 1462-1464 RelatedInformation
更多
查看译文
关键词
sickle cell patients,reduced cell transfusions,voxelotor—experience,hospitalizations
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要